Frailty in Cardiovascular Disease

Details of the Concept

Frailty is a multidimensional syndrome of reduced physiological reserve and increased vulnerability to stressors, characterized by decreased physical function, nutritional deficiencies, and susceptibility to adverse outcomes. In cardiovascular disease, frailty is highly prevalent (68% frail or prefrail in elderly post-MI patients) and independently predicts rehospitalization, disability, and death. Despite its powerful prognostic value, frailty is underassessed in routine cardiac care. Structured multidomain rehabilitation that includes physical exercise, dietary counseling, and CV risk factor management can meaningfully improve physical performance and reduce cardiovascular hospitalizations in frail elderly patients after MI (PIpELINe trial, NEJM 2025).

Key Facts

Assessment Tools

Short Physical Performance Battery (SPPB)

• Validated, standardized measure of global physical function; widely used in older patients with frailty; predictive of disability, mortality, and major adverse cardiac events
• Score 0–12; lower score = more severe impairment; three equally weighted components:
  1. Standing balance test
  2. 4-m gait speed test
  3. Strength test: time to rise from a chair five times
• SPPB 4–9 = impaired but not maximally compromised — the actionable rehabilitation zone in PIpELINe (neither too fit to benefit nor too compromised for intervention to be feasible)
• Predicts all-cause mortality across multiple populations (Pavasini 2016 BMC Med systematic review) (sources/pipeline-mi-nejm-2025, rating: very high)

Fried's Frailty Phenotype (5 Components)

• (1) Unintentional weight loss; (2) self-reported exhaustion; (3) weak grip strength on dynamometry; (4) slow walking speed; (5) low physical activity
• Frail: ≥3 components; Prefrail: 1–2 components; Robust: 0 components
• In PIpELINe post-MI elderly cohort (median age 80): frail 4%, prefrail 64%, robust 32%; 68% combined frail/prefrail (sources/pipeline-mi-nejm-2025, rating: very high)

Other Functional Measures

• Hand-grip strength: independently predicts cardiac adverse events in pooled individual-patient meta-analysis (Pavasini 2019 Heart)
• 10-m gait speed: slow gait speed predicts reduced CR participation after MI (Flint 2018 J Am Heart Assoc)
• Timed Up and Go (TUG): ≥12 s = fall risk; used at cardiac rehabilitation entry (AHA/AACVPR 2024) (sources/cardiac-rehab-aha-2024, rating: very high)
• Berg Balance Scale: 41–56 independent; 21–40 walking assistance needed; 0–20 wheelchair-bound
• 30-Second Chair Stand: age/sex normative data; identifies lower-extremity strength impairment

Frailty and Post-MI Trajectory

• After MI, older adults represent the least physically active group; physical decline, disability, and loss of independence accelerate post-event
• Aerobic capacity declines >20% per decade after age 70 (Fleg 2005 Circulation); functional recovery after ACS is disproportionately impaired in this population
• Frailty and impaired physical performance at 1 month post-MI independently predict 1-year CV death and CV rehospitalization (sources/pipeline-mi-nejm-2025, rating: very high)
• Malnutrition co-occurs with frailty and further increases adverse event risk post-ACS (Tonet 2020 Clin Nutr)
• SPPB and grip strength improve prediction of major adverse cardiac events in elderly ACS patients beyond traditional risk scores (Campo 2020 J Gerontol)

Multidomain Rehabilitation in Frail/Elderly Post-MI Patients — PIpELINe Trial (NEJM 2025)

• Design: multicenter RCT; 7 Italian sites; n=512 (342 intervention, 170 control); median age 80; 36% women; 68% frail/prefrail; SPPB 4–9 at 1 month post-MI; 2:1 allocation (sources/pipeline-mi-nejm-2025, rating: very high)
• Intervention (12 months): CV risk factor management + dietary counseling + exercise training (Otago Program: balance/strength exercises; ≥20 min moderate walking ≥4×/week; 6 on-site supervised sessions; home-based between sessions; intensity from 1-km treadmill test)
• Primary outcome (CV death or unplanned CV hospitalization at 1 year): HR 0.57 (95% CI 0.36–0.89; P=0.01); NNT ≈12.5
• HF hospitalization: HR 0.20 (95% CI 0.07–0.56) — most dramatic reduction
• CV death: HR 0.69 (NS); Unplanned CV hospitalization: HR 0.48
• Physical performance: SPPB, gait speed, and grip strength all improved at 6 months and 1 year
• Quality of life (EQ-5D-5L): improved with intervention
• No serious adverse events; compliance 71% overall (75% excluding deaths)
• Subgroup benefit consistent across diabetes, CKD, LVEF ≤40%, prefrail status, NSTEMI, age ≥75

Frailty and Invasive Strategy in Elderly NSTEMI — SENIOR-RITA (NEJM 2024)

• 32.4% of SENIOR-RITA patients (n=1,518; mean age 82) were frail by the Fried Frailty Index (≥3 criteria); 62.5% had cognitive impairment (MoCA <26); median Charlson Comorbidity Index was 5 (sources/PCI-Elderly-SENIORRITA-NEJM-2024, rating: very high)
• Despite this high-risk frail population, coronary angiography was safe: radial access in 89.3%, procedural complications <1% — frailty is NOT a contraindication to angiography per se (sources/PCI-Elderly-SENIORRITA-NEJM-2024, rating: very high)
• Subgroup analyses in SENIOR-RITA showed findings consistent across frail and non-frail patients — the neutral primary result was not driven by frailty as an effect modifier (sources/PCI-Elderly-SENIORRITA-NEJM-2024, rating: very high)
• The Fried Frailty Index and modified Rockwood Clinical Frailty Scale were both used in SENIOR-RITA; Rockwood ≥5 defined frailty for stratification (sources/PCI-Elderly-SENIORRITA-NEJM-2024, rating: very high)
• Frailty assessment at the time of NSTEMI presentation should inform shared decision-making about invasive strategy: frailty increases competing non-cardiovascular mortality, which limits long-term benefit from coronary revascularisation (sources/PCI-Elderly-SENIORRITA-NEJM-2024, rating: very high)
• See concepts/NSTEMI-Elderly-Invasive-Strategy for the full trial synthesis and clinical interpretation

Frailty in Other Cardiovascular Contexts

• Frail/prefrail patients are systematically under-enrolled in traditional hospital-based cardiac rehabilitation (sources/cardiac-rehab-aha-2024, rating: very high)
• AHA/AACVPR 2024 strength training component specifically targets frailty and fall prevention as a standalone goal
• Frailty assessment at CR entry (SPPB, grip strength, gait speed, TUG) is recommended; strength training component addresses sarcopenia
• Class III obesity is a relative contraindication to cardiac transplantation; frailty similarly heightens perioperative risk across cardiac procedures

Contradictions / Open Questions

• No benefit in PAD subgroup: PIpELINe participants with peripheral artery disease showed HR 1.06 (no benefit) despite the overall trial benefit (HR 0.57); PAD likely limits exercise adherence and functional response; unclear whether dietary/risk factor components alone provide benefit in this subgroup (sources/pipeline-mi-nejm-2025, rating: very high)
• Frail vs. prefrail threshold: Paradoxically, the "frail" subgroup (≥3 Fried criteria, n=31) showed HR 0.87 (numerically no benefit), whereas prefrail showed HR 0.48 (strong benefit); sample too small for definitive conclusion; optimal SPPB or Fried threshold for patient selection remains empirical
• Cognitive impairment gap: PIpELINe excluded patients with cognitive impairment; frailty and cognitive decline co-occur frequently in post-MI elderly; no data to guide rehabilitation in this combined high-risk population
• Longer-term durability: 1-year benefit is established; whether it persists or erodes at 2–3 years is unknown; longer follow-up ongoing
• Component isolation: Multidomain design precludes determining whether exercise, diet, or risk factor management individually drives the benefit; cannot optimize resource-limited implementation
• Frailty as effect modifier in SENIOR-RITA — no significant interaction: SENIOR-RITA enrolled 32% frail NSTEMI patients but found no significant benefit or harm from invasive strategy in the frail subgroup (consistent across frail/non-frail). This argues against routine exclusion of frail elderly from angiography — frailty increases absolute procedural risk but also absolute background event rate, potentially maintaining or narrowing relative risk. However, the neutral overall primary result means neither frail nor non-frail patients showed a clear aggregate benefit from routine invasive management. (sources/PCI-Elderly-SENIORRITA-NEJM-2024, rating: very high)

Connections

• Related to concepts/Cardiac-Rehabilitation — frailty as key barrier and rehabilitation target; PIpELINe as the RCT evidence base for tailored CR in elderly post-MI
• Related to entities/Acute-Coronary-Syndrome — post-MI frailty prevalence and secondary prevention context
• Related to entities/Heart-Failure — HF hospitalization heavily reduced in frail post-MI patients; parallel with REHAB-HF trial
• Related to entities/Peripheral-Artery-Disease — PAD subgroup did not benefit from multidomain rehabilitation (PIpELINe HR 1.06)
• Related to concepts/PAD-Exercise-Therapy — exercise therapy context for PAD patients
• Related to concepts/NSTEMI-Elderly-Invasive-Strategy — SENIOR-RITA; frailty and safety of invasive management in elderly NSTEMI

Sources

• sources/pipeline-mi-nejm-2025
• sources/cardiac-rehab-aha-2024
• sources/PCI-Elderly-SENIORRITA-NEJM-2024